Skip to search formSkip to main contentSkip to account menu

Ropinirole hydrochloride

Known as: 2(H)-Indol-2-one, 4-(2-(dipropylamino)ethyl)-1,3-dihydro-, Monohydrochloride, 4-(2-(Dipropylamino)ethyl)-2-indolinone Monohydrochloride, ropinirole hcl 
The hydrochloride salt form of ropinirole, a non-ergot dopamine agonist with antiparkinsonian property. Acting as a substitute for dopamine… 
National Institutes of Health

Related topics

Related topics

9 relations
24 HR ropinirole 12 MG Extended Release Oral Tablet [Requip]24 HR ropinirole 6 MG Extended Release Oral TabletDrug AllergyParkinson Disease

Narrower (2)

RequipSK&F 101468-A

Broader (1)

ropinirole

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
3D printing of tablets using inkjet with UV photoinitiation.
2013
2013
Controlled delivery of ropinirole hydrochloride through skin using modulated iontophoresis and microneedles
Abstract The objective of this study was to investigate the effect of modulated current application using iontophoresis- and… 
Highly Cited
2012
Highly Cited
2012
Formulation and Evaluation of Mouth Dissolving Film of Ropinirole Hydrochloride by Using Pullulan Polymers
The present work aimed at preparing mouth dissolvin g films of Ropinirole Hydrochloride with the purpose of developing a dosage… 
Review
2012
Review
2012
A novel nonsense mutation in the TITF-1 gene in a Japanese family with benign hereditary chorea
2011
2011
Sustained release microspheres of ropinirole hydrochloride: Effect of process parameters
Sustained release microspheres of ropinirole hydrochloride: Effect of process parameters An emulsion solvent evaporation method… 
Highly Cited
2010
Highly Cited
2010
Nanoencapsulation of a water soluble drug in biocompatible polyesters. Effect of polyesters melting point and glass transition temperature on drug release behavior.
Highly Cited
2004
Highly Cited
2004
Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
BACKGROUND Patients with Parkinson disease (PD) treated with the nonergot dopamine agonists pramipexole dihydrochloride and… 
2003
2003
In vivo iontophoretic administration of ropinirole hydrochloride.
This work explores the possibility of achieving therapeutic levels of the anti-Parkinsonian drug, ropinirole hydrochloride (RHCl… 
Highly Cited
2001
Highly Cited
2001
Iontophoretic Delivery of Ropinirole Hydrochloride: Effect of Current Density and Vehicle Formulation
AbstractPurpose. The objectives of this work were 1) to establish the feasibility of the transdermal iontophoretic delivery of… 
Highly Cited
1999
Highly Cited
1999
Disposition of ropinirole in animals and man.
1. The disposition and metabolic fate of ropinirole, a novel compound indicated for the symptomatic treatment of Parkinson's… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)